Biochemistry, Genetics and Molecular Biology
Induced Pluripotent Stem Cell
100%
Stem Cell Line
77%
Fibroblast
42%
Retinitis pigmentosa
37%
ABCA4
33%
Photosynthetic Pigment
28%
SOX2
25%
LIN28
25%
KLF4
25%
Episome
22%
MicroRNA
20%
USH2A
19%
PRPF31
19%
Reprogramming
19%
Small Hairpin RNA
18%
Karyotype
17%
Exon
16%
CRB1
14%
Photoreceptor Cell
12%
P53
12%
Gene Expression
12%
Genetics
11%
Microperimetry
11%
Autosomal Recessive Inheritance
10%
Stem Cell Marker
10%
Dideoxynucleotide Sequencing
9%
Splicing Defect
9%
CLN3
9%
Germ Layer
9%
Messenger RNA
7%
Antisense
7%
Autofluorescence
7%
Optics
7%
Penetrance
7%
Allele
6%
Clinical Trial
6%
Genetic Determinism
6%
Genomics
6%
Stem Cell
6%
Cilium
6%
Autosomal Dominant Inheritance
5%
Visual Acuity
5%
Precursor mRNA
5%
Genetic Disorder
5%
Neuronal Ceroid Lipofuscinosis
5%
Batten Disease
5%
Oligonucleotide
5%
Retinal
5%
Electroretinography
5%
RNA Splicing
5%
Medicine and Dentistry
Induced Pluripotent Stem Cell
24%
Retinopathy
22%
Visual Pigment
20%
Retina Disease
16%
Retinitis pigmentosa
15%
Retina Dystrophy
14%
Optical Coherence Tomography
14%
Branch Retinal Vein Occlusion
14%
Autofluorescence
13%
Epithelial Cell
13%
Diseases
12%
Clinical Trial
11%
Retinal Pigment Epithelium
11%
Electroretinography
10%
Messenger RNA Precursor
9%
Usher Syndrome
9%
Triamcinolone Acetonide
9%
Bevacizumab
9%
Cytokine
9%
Stem Cell
9%
Pluripotent Stem Cell Line
9%
Photoreceptor
8%
Fibroblast
8%
Vasculotropin
8%
Visual Acuity
8%
Diabetic Retinopathy
7%
Eye Disease
7%
Gene Expression
7%
Disease
7%
Sanger Sequencing
6%
Disease Exacerbation
6%
Clinical Observation
6%
Western Blot
6%
Retina Degeneration
5%
Spectral Domain Optical Coherence Tomography
5%
Vascularity
5%
Agents Acting on the Eye
5%
Nerve Cell Degeneration
5%
Cell Death
5%
Microglia
5%
Visual Impairment
5%
Combination Therapy
5%
Immunohistochemistry
5%
Neuroscience
Retinal Disease
29%
Visual Pigment
14%
Retinal Vein Occlusion
14%
Epithelial Cells
12%
Age-Related Macular Degeneration
11%
Retinitis pigmentosa
11%
Retinal Pigment Epithelium
9%
PRPF31
9%
Sensation of Hearing
9%
Cochlea
9%
Bevacizumab
9%
Triamcinolone Acetonide
9%
Gene Expression
7%
Vascular Endothelial Growth Factor
7%
Cell Therapy
6%
CRISPR
6%
Fibroblast
6%
Nerve Cell Degeneration
5%
Cilium
5%
Stem Cell
5%